Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kintara Therapeutics, Inc. | Chief Financial Officer | Options (Right to Buy) | 66.7K | Oct 18, 2024 | Direct | ||
Kintara Therapeutics, Inc. | Chief Financial Officer | Common Stock | 0 | Oct 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KTRA | Kintara Therapeutics, Inc. | Oct 18, 2024 | 5 | $0 | 4 | Oct 22, 2024 | Chief Financial Officer |
KTRA | Kintara Therapeutics, Inc. | Oct 18, 2024 | 0 | $0 | 3 | Oct 22, 2024 | Chief Financial Officer |